Skip to menu Skip to content Skip to footer

2000

Journal Article

Sedation in terminally ill patients

Hardy, J (2000). Sedation in terminally ill patients. Lancet, 356 (9245), 1866-1867. doi: 10.1016/S0140-6736(00)03252-9

Sedation in terminally ill patients

2000

Journal Article

Fatigue in patients with prostate cancer receiving hormone therapy

Stone, P, Hardy, J, Huddart, R, A'Hern, R and Richards, M (2000). Fatigue in patients with prostate cancer receiving hormone therapy. European Journal of Cancer, 36 (9), 1134-1141. doi: 10.1016/S0959-8049(00)00084-8

Fatigue in patients with prostate cancer receiving hormone therapy

2000

Journal Article

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer

Stone, P, Richards, M, A'Hern, R and Hardy, J (2000). A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology, 11 (5), 561-567. doi: 10.1023/A:1008331230608

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer

2000

Journal Article

Outcome of malignant spinal cord compression at a cancer center: Implications for palliative care services

Cowap, J, Hardy, JR and A'Hern, R (2000). Outcome of malignant spinal cord compression at a cancer center: Implications for palliative care services. Journal of Pain and Symptom Management, 19 (4), 257-264. doi: 10.1016/S0885-3924(00)00110-X

Outcome of malignant spinal cord compression at a cancer center: Implications for palliative care services

2000

Journal Article

What influences participation in clinical trials in palliative care in a cancer centre?

Ling, J, Rees, E and Hardy, J (2000). What influences participation in clinical trials in palliative care in a cancer centre?. European Journal of Cancer, 36 (5), 621-626. doi: 10.1016/S0959-8049(99)00330-5

What influences participation in clinical trials in palliative care in a cancer centre?

1999

Journal Article

The use of the Rotterdam symptom checklist in palliative care

Hardy, JR, Edmonds, P, Turner, R, Rees, E and A'Hern, R (1999). The use of the Rotterdam symptom checklist in palliative care. Journal of Pain and Symptom Management, 18 (2), 79-84. doi: 10.1016/S0885-3924(99)00050-0

The use of the Rotterdam symptom checklist in palliative care

1999

Journal Article

Fatigue in advanced cancer: a prospective controlled cross-sectional study

Stone, P., Hardy, J., Broadley, K., Tookman, A. J., Kurowska, A. and A'Hern, R. (1999). Fatigue in advanced cancer: a prospective controlled cross-sectional study. British Journal of Cancer, 79 (9-10), 1479-1486. doi: 10.1038/sj.bjc.6690236

Fatigue in advanced cancer: a prospective controlled cross-sectional study

1998

Journal Article

Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction

Hardy, J, Ling, J, Mansi, J, Isaacs, R, A'Hern, R, Blake, P, Gore, M, Shepherd, J and Hanks, G (1998). Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine, 12 (6), 437-442. doi: 10.1191/026921698666334766

Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction

1998

Journal Article

Fatigue in patients with cancer

Stone, P, Richards, M and Hardy, J (1998). Fatigue in patients with cancer. European Journal of Cancer, 34 (11), 1670-1676. doi: 10.1016/S0959-8049(98)00167-1

Fatigue in patients with cancer

1998

Journal Article

Thioridazine in the management of cancer-related sweating

Cowap, J and Hardy, J (1998). Thioridazine in the management of cancer-related sweating. Journal of Pain and Symptom Management, 15 (5), 266-266.

Thioridazine in the management of cancer-related sweating

1998

Journal Article

A survey of transdermal fentanyl use in a major cancer center

Hardy, JR (1998). A survey of transdermal fentanyl use in a major cancer center. Journal of Pain and Symptom Management, 15 (4), 213-214.

A survey of transdermal fentanyl use in a major cancer center

1998

Journal Article

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

Rees, E, Hardy, J, Ling, J, Broadley, K and A'Hern, R (1998). The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliative Medicine, 12 (2), 75-82. doi: 10.1191/026921698674135173

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

1997

Journal Article

Placebo-controlled trials in palliative care: the argument for

Hardy, JR (1997). Placebo-controlled trials in palliative care: the argument for. Palliative Medicine, 11 (5), 415-418. doi: 10.1177/026921639701100514

Placebo-controlled trials in palliative care: the argument for

1997

Journal Article

Palliative medicine in cancer

Stone, Patrick and Hardy, Janet (1997). Palliative medicine in cancer. The Lancet, 350 (9073), 296. doi: 10.1016/s0140-6736(05)62270-2

Palliative medicine in cancer

1997

Journal Article

Can transdermal fentanyl cause diarrhea?

Hardy, Janet R. (1997). Can transdermal fentanyl cause diarrhea?. Journal of Pain and Symptom Management, 13 (4), 188-189. doi: 10.1016/s0885-3924(97)00037-7

Can transdermal fentanyl cause diarrhea?

1995

Journal Article

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD)

Ling, P. J., Ahern, R. P. and Hardy, J. R. (1995). Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). British Journal of Cancer, 72 (1), 206-209. doi: 10.1038/bjc.1995.304

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD)

1995

Journal Article

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

Ellis, P. A., Smith, I. E., Hardy, J. R., Nicolson, M. C., Talbot, D. C., Ashley, S. E. and Priest, K. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. British Journal of Cancer, 71 (2), 366-370. doi: 10.1038/bjc.1995.74

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

1995

Journal Article

Subcutaneous Ketorolac

Duncan, AR, Hardy, JR and Davis, CL (1995). Subcutaneous Ketorolac. Palliative Medicine, 9 (1), 77-78. doi: 10.1177/026921639500900111

Subcutaneous Ketorolac

1994

Journal Article

Current issues in cancer palliative care

Davis, C. L. and Hardy, J. R. (1994). Current issues in cancer palliative care. BMJ, 308 (6940), 1359-1362. doi: 10.1136/bmj.308.6940.1359

Current issues in cancer palliative care

1994

Journal Article

Prediction of Survival in a Hospital-Based Continuing Care Unit

Hardy, JR, Turner, R, Saunders, M and Ahern, R (1994). Prediction of Survival in a Hospital-Based Continuing Care Unit. European Journal of Cancer, 30A (3), 284-288. doi: 10.1016/0959-8049(94)90242-9

Prediction of Survival in a Hospital-Based Continuing Care Unit